Endocardial left ventricular pacing for cardiac resynchronization: systematic review and meta-analysis
James Hugo Phillimore Gamble1, Neil Herring1, Matthew Ginks1
1Department of Cardiology, Oxford Heart Centre, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
Summary
Endocardial left ventricular pacing offers a viable alternative for Cardiac Resynchronization Therapy (CRT) when traditional methods fail. While clinical response rates are comparable, there
Area of Science:
- Cardiology
- Medical Devices
- Electrophysiology
Background:
- Conventional Cardiac Resynchronization Therapy (CRT) involves left ventricular (LV) lead placement via the coronary sinus.
- Endocardial LV pacing presents an alternative strategy for CRT delivery.
- Assessing the efficacy and safety of endocardial LV pacing is crucial for patient selection.
Purpose of the Study:
- To conduct a meta-analysis evaluating the benefits and risks of endocardial LV pacing compared to conventional CRT.
- To determine the clinical response rates and complication profiles associated with endocardial LV pacing.
Main Methods:
- Systematic literature search of online databases for studies on lead-based endocardial pacing.
- Random-effects meta-analysis to assess procedural success, clinical response (≥1 NYHA class decrease), and complication rates.
- Inclusion of 23 studies with 384 patients, analyzing various endocardial pacing techniques (trans-atrial septal, trans-ventricular apical, trans-ventricular septal).
Main Results:
- Procedural success rates exceeded 95% across all included studies.
- An overall clinical response estimate of 82% (95% CI 71-89%) was observed, with significant heterogeneity noted.
- Thromboembolic complications included stroke at 2.5 events/100 patient-years and TIA at 2.6 events/100 patient-years; mortality rate was 4.5 events/100 patient-years.
Conclusions:
- Endocardial LV pacing is a feasible option, particularly when conventional lead placement is challenging.
- Clinical response rates are comparable to conventional CRT, despite observed heterogeneity.
- A slight increase in stroke risk may be associated with endocardial pacing, especially in high-risk patient populations.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
564
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
564
Cardiomyopathy II: Dilated Cardiomyopathy
689
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
689
Electrophysiology of Normal Cardiac Rhythm
10.0K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
10.0K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
593
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
593
Cardiomyopathy IV: Restrictive Cardiomyopathy
699
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
699


